These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 33297781)
1. Morelli M; Galluzzo M; Madonna S; Scarponi C; Scaglione GL; Galluccio T; Andreani M; Pallotta S; Girolomoni G; Bianchi L; Talamonti M; Albanesi C Expert Opin Biol Ther; 2021 Feb; 21(2):259-270. PubMed ID: 33297781 [No Abstract] [Full Text] [Related]
2. Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study. Costanzo A; Bianchi L; Flori ML; Malara G; Stingeni L; Bartezaghi M; Carraro L; Castellino G; Br J Dermatol; 2018 Nov; 179(5):1072-1080. PubMed ID: 29704432 [TBL] [Abstract][Full Text] [Related]
3. Allelic Variants of HLA-C Upstream Region, Morelli M; Galluzzo M; Scarponi C; Madonna S; Scaglione GL; Girolomoni G; Talamonti M; Bianchi L; Albanesi C Vaccines (Basel); 2022 Nov; 10(11):. PubMed ID: 36423071 [TBL] [Abstract][Full Text] [Related]
4. Genetic variations in IL6 and IL12B decreasing the risk for psoriasis. Boca AN; Talamonti M; Galluzzo M; Botti E; Vesa SC; Chimenti S; Buzoianu AD; Costanzo A Immunol Lett; 2013; 156(1-2):127-31. PubMed ID: 24140476 [TBL] [Abstract][Full Text] [Related]
5. Response to IL-17A inhibitors secukinumab and ixekizumab cannot be explained by genetic variation in the protein-coding and untranslated regions of the IL-17A gene: results from a multicentre study of four European psoriasis cohorts. van Vugt LJ; van den Reek JMPA; Meulewaeter E; Hakobjan M; Heddes N; Traks T; Kingo K; Galluzzo M; Talamonti M; Lambert J; Coenen MJH; de Jong EMGJ J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):112-118. PubMed ID: 31287604 [TBL] [Abstract][Full Text] [Related]
6. Increased Risk of Psoriasis due to combined effect of HLA-Cw6 and LCE3 risk alleles in Indian population. Chandra A; Lahiri A; Senapati S; Basu B; Ghosh S; Mukhopadhyay I; Behra A; Sarkar S; Chatterjee G; Chatterjee R Sci Rep; 2016 Apr; 6():24059. PubMed ID: 27048876 [TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab. Talamonti M; Botti E; Galluzzo M; Teoli M; Spallone G; Bavetta M; Chimenti S; Costanzo A Br J Dermatol; 2013 Aug; 169(2):458-63. PubMed ID: 23521149 [TBL] [Abstract][Full Text] [Related]
8. Human leucocyte antigen-Cw6 as a predictor for clinical response to ustekinumab, an interleukin-12/23 blocker, in Chinese patients with psoriasis: a retrospective analysis. Chiu HY; Wang TS; Chan CC; Cheng YP; Lin SJ; Tsai TF Br J Dermatol; 2014 Nov; 171(5):1181-8. PubMed ID: 24734995 [TBL] [Abstract][Full Text] [Related]
9. SPR1 gene near HLA-C is unlikely to be a psoriasis susceptibility gene. Chang YT; Tsai SF; Lin MW; Liu HN; Lee DD; Shiao YM; Chin PJ; Wang WJ Exp Dermatol; 2003 Jun; 12(3):307-14. PubMed ID: 12823445 [TBL] [Abstract][Full Text] [Related]
10. HLA antigens may influence the age of onset of psoriasis and psoriatic arthritis. Queiro R; Torre JC; González S; López-Larrea C; Tinturé T; López-Lagunas I J Rheumatol; 2003 Mar; 30(3):505-7. PubMed ID: 12610809 [TBL] [Abstract][Full Text] [Related]
11. HLA-Cw6-positive patients with psoriasis show improved response to methotrexate treatment. West J; Ogston S; Berg J; Palmer C; Fleming C; Kumar V; Foerster J Clin Exp Dermatol; 2017 Aug; 42(6):651-655. PubMed ID: 28512993 [TBL] [Abstract][Full Text] [Related]
12. Combined effects of HLA-Cw6, body mass index and waist-hip ratio on psoriasis vulgaris in Chinese Han population. Jin Y; Zhang F; Yang S; Kong Y; Xiao F; Hou Y; Fan X; Zhang X J Dermatol Sci; 2008 Nov; 52(2):123-9. PubMed ID: 18585007 [TBL] [Abstract][Full Text] [Related]
13. Stronger association with HLA-Cw6 than with corneodesmosin (S-gene) polymorphisms in Swedish psoriasis patients. Enerbäck C; Nilsson S; Enlund F; Inerot A; Samuelsson L; Wahlström J; Swanbeck G; Martinsson T Arch Dermatol Res; 2000 Nov; 292(11):525-30. PubMed ID: 11194889 [TBL] [Abstract][Full Text] [Related]
14. Fine mapping of the psoriasis susceptibility locus PSORS1 supports HLA-C as the susceptibility gene in the Han Chinese population. Fan X; Yang S; Huang W; Wang ZM; Sun LD; Liang YH; Gao M; Ren YQ; Zhang KY; Du WH; Shen YJ; Liu JJ; Zhang XJ PLoS Genet; 2008 Mar; 4(3):e1000038. PubMed ID: 18369457 [TBL] [Abstract][Full Text] [Related]
15. HLA-Cw6 and HLA-DRB1*07 together are associated with less severe joint disease in psoriatic arthritis. Ho PY; Barton A; Worthington J; Thomson W; Silman AJ; Bruce IN Ann Rheum Dis; 2007 Jun; 66(6):807-11. PubMed ID: 17223660 [TBL] [Abstract][Full Text] [Related]
16. The HLA-Cw6 Dilemma: Is It Really an Outcome Predictor in Psoriasis Patients under Biologic Therapy? A Monocentric Retrospective Analysis. Burlando M; Russo R; Clapasson A; Carmisciano L; Stecca A; Cozzani E; Parodi A J Clin Med; 2020 Sep; 9(10):. PubMed ID: 32998429 [TBL] [Abstract][Full Text] [Related]
17. Association of IL12B risk haplotype and lack of interaction with HLA-Cw6 among the psoriasis patients in India. Chandra A; Senapati S; Ghosh S; Chatterjee G; Chatterjee R J Hum Genet; 2017 Mar; 62(3):389-395. PubMed ID: 27829679 [TBL] [Abstract][Full Text] [Related]
18. Identifying the genetic associations among the psoriasis patients in eastern India. Das S; Chandra A; Das A; Senapati S; Chatterjee G; Chatterjee R J Hum Genet; 2024 May; 69(5):205-213. PubMed ID: 38409498 [TBL] [Abstract][Full Text] [Related]
19. Clinical associations of the risk alleles of HLA-Cw6 and CCHCR1*WWCC in psoriasis. Suomela S; Kainu K; Onkamo P; Tiala I; Himberg J; Koskinen L; Snellman E; Karvonen SL; Karvonen J; Uurasmaa T; Reunala T; Kivikäs K; Jansén CT; Holopainen P; Elomaa O; Kere J; Saarialho-Kere U Acta Derm Venereol; 2007; 87(2):127-34. PubMed ID: 17340018 [TBL] [Abstract][Full Text] [Related]
20. HLA-Cw6 allele, NFkB1 and NFkBIA polymorphisms play no role in predicting response to etanercept in psoriatic patients. Caldarola G; Sgambato A; Fanali C; Moretta G; Farina M; Lucchetti D; Peris K; De Simone C Pharmacogenet Genomics; 2016 Sep; 26(9):423-7. PubMed ID: 27348478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]